查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1476497

药物发现外包的市场规模 - 按工作流程、治疗领域、药物类型和最终用户划分 - 区域前景、竞争策略和细分市场预测（截至 2033 年）

Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到2033年，全球药物发现外包市场规模将成长至85.9亿美元，复合年增长率为7.71%。

药物发现外包是药理学、生技和製药等各领域发现新药和治疗方法的方式之一。这种方法的成功率相对较低，并且是一个劳动密集过程。然而，在该行业中，大大小小的参与者开发新药并将其提供给较大的参与者进行临床后测试，以检验和保证药物的有效性。

COVID-19 对药物发现行业产生了重大影响。这是由于过去三年製药和生物技术公司对疫苗的高需求。为了创造强大的抗病毒药物，在药物研究中藉用外部帮助变得至关重要。随着生物技术和製药行业的公司将研究委託给 CRO，COVID-19 对市场成长产生了重大影响。这些业务包括使用体外和体内模型的基础研究以及早期临床开发。

该报告调查了全球药物发现外包市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局以及主要企业。。

目录

第一章简介

第二章调查方法

第三章执行摘要

第四章市场动态

  • 促进因素、抑制因素、机会与挑战分析
  • COVID-19 对市场的影响

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争状况

  • 製造地、销售区域、产品类型分布
  • 併购、联盟、产品发布、合作

第七章 全球药物发现外包市场：依工作流程

  • 全球市占率及预测
  • 目标验证/功能资讯学
  • 潜在客户识别/候选优化
  • 临床前开发
  • 目标识别/筛检
  • 其他的

第八章 全球药物发现外包市场：依治疗领域

  • 全球市占率及预测
  • 心血管
  • 中枢神经系统
  • 胃
  • 血
  • 呼吸系统
  • 感染疾病
  • 瘤
  • 免疫
  • 其他的

第九章全球药物发现外包市场：依药物类型

  • 全球市占率及预测
  • 低分子
  • 高分子

第10章全球药物发现外包市场：依最终用户分类

  • 市场规模/市场占有率趋势/预测
  • 製药和生物技术公司
  • 学术机构
  • 其他的

第十一章 全球药物发现外包市场预测

  • 市场规模/市场占有率趋势/预测

第十二章全球药物发现外包市场：按地区

  • 市场规模/市场占有率趋势/预测
  • 亚太地区
  • 欧洲
  • 中东/非洲
  • 北美洲
  • 拉丁美洲

第十三章 公司简介

  • Charles River Laboratories
  • Curia Global Inc.
  • Dalton Pharma Service
  • Dr. Reddy's Laboratories
  • Discover X Corporation
  • Laboratory Corporation of America
  • Merck & Co
  • Syngene International Ltd.
  • TCG Life Science Pvt. Ltd.
  • Thermo Fisher Scientific, Inc.
  • 其他的

第14章简称

第十五章 参考链接

第16章结论

第十七章 研究范围

简介目录
Product Code: HLCA2436

Drug Discovery Outsourcing Market Introduction and Overview

According to SPER market research, Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Drug Discovery Outsourcing Market is predicted to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.

One way to uncover new medications or therapeutics in a variety of sectors, including pharmacology, biotechnology, and pharmaceuticals, is through drug discovery outsourcing. This approach has a relatively poor success rate in drug development and is a labor-intensive procedure. Nonetheless, both large and tiny producers in the industry create novel medications and provide them to well-known competitors for examination after clinical trials to determine and guarantee the medications' efficacy.

Because several pharmaceutical and biotech businesses have been in high demand for vaccine discovery over the last three years, COVID-19 has had a substantial influence on the drug discovery industry. Using outside help for drug research has become essential to creating potent anti-virus therapies. Because businesses in the biotech and pharmaceutical sectors were progressively outsourcing research efforts to CROs, COVID-19 had a major effect on the market's growth. These operations comprised basic research employing in vitro and in vivo models as well as early-stage clinical development.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Workflow, By Therapeutic Area, By Drug Type, By End User.

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy's Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd.

Drug Discovery Outsourcing Market Segmentation

By Workflow: Based on the Workflow, Global Drug Discovery Outsourcing Market is segmented as; Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others.

By Therapeutic Area: Based on the Therapeutic Area, Global Drug Discovery Outsourcing Market is segmented as; Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiration System, Infectious Disease, Oncology, Immunology, Others

By Drug Type: Based on the Drug Type, Global Drug Discovery Outsourcing Market is segmented as; Small Molecules, Large Molecules.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market

7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033

  • 7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-2026
  • 7.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-2033
  • 7.3. Target Validation and Functional Informatics
  • 7.4. Lead Identification and Candidate Optimization
  • 7.5. Preclinical Development
  • 7.6. Target Identification and Screening
  • 7.7. Others

8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033

  • 8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)
  • 8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)
  • 8.3. Cardiovascular
  • 8.4. Central Nervous System
  • 8.5. Gastrointestinal
  • 8.6. Haematology
  • 8.7. Respiratory System
  • 8.8. Infectious Disease
  • 8.9. Oncology
  • 8.10. Immunology
  • 8.11. Others

9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033

  • 9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)
  • 9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)
  • 9.3. Small Molecules
  • 9.4. Large Molecules

10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033

  • 10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)
  • 10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)
  • 10.3. Pharmaceutical and Biotechnological Companies
  • 10.4. Academia Institutions
  • 10.5. Others

11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)

  • 11.1. Global Drug Discovery Outsourcing Market Size and Market Share

12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)

  • 12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)
  • 12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)
  • 12.3. Asia-Pacific
    • 12.3.1. Australia
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. Japan
    • 12.3.5. South Korea
    • 12.3.6. Rest of Asia-Pacific
  • 12.4. Europe
    • 12.4.1. France
    • 12.4.2. Germany
    • 12.4.3. Italy
    • 12.4.4. Spain
    • 12.4.5. United Kingdom
    • 12.4.6. Rest of Europe
  • 12.5. Middle East and Africa
    • 12.5.1. Kingdom of Saudi Arabia
    • 12.5.2. United Arab Emirates
    • 12.5.3. Qatar
    • 12.5.4. South Africa
    • 12.5.5. Egypt
    • 12.5.6. Morocco
    • 12.5.7. Nigeria
    • 12.5.8. Rest of Middle-East and Africa
  • 12.6. North America
    • 12.6.1. Canada
    • 12.6.2. Mexico
    • 12.6.3. United States
  • 12.7. Latin America
    • 12.7.1. Argentina
    • 12.7.2. Brazil
    • 12.7.3. Rest of Latin America

13. Company Profile

  • 13.1. Charles River Laboratories
    • 13.1.1. Company details
    • 13.1.2. Financial outlook
    • 13.1.3. Product summary
    • 13.1.4. Recent developments
  • 13.2. Curia Global Inc.
    • 13.2.1. Company details
    • 13.2.2. Financial outlook
    • 13.2.3. Product summary
    • 13.2.4. Recent developments
  • 13.3. Dalton Pharma Service
    • 13.3.1. Company details
    • 13.3.2. Financial outlook
    • 13.3.3. Product summary
    • 13.3.4. Recent developments
  • 13.4. Dr. Reddy's Laboratories
    • 13.4.1. Company details
    • 13.4.2. Financial outlook
    • 13.4.3. Product summary
    • 13.4.4. Recent developments
  • 13.5. Discover X Corporation
    • 13.5.1. Company details
    • 13.5.2. Financial outlook
    • 13.5.3. Product summary
    • 13.5.4. Recent developments
  • 13.6. Laboratory Corporation of America
    • 13.6.1. Company details
    • 13.6.2. Financial outlook
    • 13.6.3. Product summary
    • 13.6.4. Recent developments
  • 13.7. Merck & Co
    • 13.7.1. Company details
    • 13.7.2. Financial outlook
    • 13.7.3. Product summary
    • 13.7.4. Recent developments
  • 13.8. Syngene International Ltd.
    • 13.8.1. Company details
    • 13.8.2. Financial outlook
    • 13.8.3. Product summary
    • 13.8.4. Recent developments
  • 13.9. TCG Life Science Pvt. Ltd.
    • 13.9.1. Company details
    • 13.9.2. Financial outlook
    • 13.9.3. Product summary
    • 13.9.4. Recent developments
  • 13.10. Thermo Fisher Scientific, Inc.
    • 13.10.1. Company details
    • 13.10.2. Financial outlook
    • 13.10.3. Product summary
    • 13.10.4. Recent developments
  • 13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope